• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶,重症新型冠状病毒肺炎患者的独立危险因素:一项回顾性观察研究

Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study.

作者信息

Han Yi, Zhang Haidong, Mu Sucheng, Wei Wei, Jin Chaoyuan, Tong Chaoyang, Song Zhenju, Zha Yunfei, Xue Yuan, Gu Guorong

机构信息

Emergency Department, Zhongshan Hospital, Fudan University, Shanghai 20032, China.

Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.

出版信息

Aging (Albany NY). 2020 Jun 24;12(12):11245-11258. doi: 10.18632/aging.103372.

DOI:10.18632/aging.103372
PMID:32633729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7343511/
Abstract

BACKGROUND

The World Health Organization has declared coronavirus disease 2019 (COVID-19) a public health emergency of global concern. Updated analysis of cases might help identify the risk factors of illness severity.

RESULTS

The median age was 63 years, and 44.9% were severe cases. Severe patients had higher APACHE II (8.5 vs. 4.0) and SOFA (2 vs. 1) scores on admission. Among all univariable parameters, lymphocytes, CRP, and LDH were significantly independent risk factors of COVID-19 severity. LDH was positively related both with APACHE II and SOFA scores, as well as P/F ratio and CT scores. LDH (AUC = 0.878) also had a maximum specificity (96.9%), with the cutoff value of 344.5. In addition, LDH was positively correlated with CRP, AST, BNP and cTnI, while negatively correlated with lymphocytes and its subsets.

CONCLUSIONS

This study showed that LDH could be identified as a powerful predictive factor for early recognition of lung injury and severe COVID-19 cases.

METHODS

We extracted data regarding 107 patients with confirmed COVID-19 from Renmin Hospital of Wuhan University. The degree of severity of COVID-19 patients (severe vs. non-severe) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia.

摘要

背景

世界卫生组织已宣布2019冠状病毒病(COVID-19)为全球关注的突发公共卫生事件。对病例的最新分析可能有助于确定疾病严重程度的危险因素。

结果

中位年龄为63岁,44.9%为重症病例。重症患者入院时的急性生理与慢性健康状况评分系统II(APACHE II)(8.5对4.0)和序贯器官衰竭评估(SOFA)(2对1)评分更高。在所有单变量参数中,淋巴细胞、C反应蛋白(CRP)和乳酸脱氢酶(LDH)是COVID-19严重程度的显著独立危险因素。LDH与APACHE II和SOFA评分、以及氧合指数(P/F)和胸部CT评分均呈正相关。LDH(曲线下面积[AUC]=0.878)也具有最高的特异性(96.9%),临界值为344.5。此外,LDH与CRP、天门冬氨酸氨基转移酶(AST)、脑钠肽(BNP)和心肌肌钙蛋白I(cTnI)呈正相关,而与淋巴细胞及其亚群呈负相关。

结论

本研究表明,LDH可被确定为早期识别肺损伤和重症COVID-19病例的有力预测因素。

方法

我们从武汉大学人民医院提取了107例确诊COVID-19患者的数据。根据美国胸科学会社区获得性肺炎指南,在入院时定义COVID-19患者的严重程度(重症与非重症)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/f1a28c6b8180/aging-12-103372-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/c05a70330c16/aging-12-103372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/f732e1a65ff9/aging-12-103372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/d962db8e8bf8/aging-12-103372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/f1a28c6b8180/aging-12-103372-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/c05a70330c16/aging-12-103372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/f732e1a65ff9/aging-12-103372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/d962db8e8bf8/aging-12-103372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7343511/f1a28c6b8180/aging-12-103372-g004.jpg

相似文献

1
Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study.乳酸脱氢酶,重症新型冠状病毒肺炎患者的独立危险因素:一项回顾性观察研究
Aging (Albany NY). 2020 Jun 24;12(12):11245-11258. doi: 10.18632/aging.103372.
2
Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.血清乳酸脱氢酶与性别相结合可预测COVID-19患者的重症疾病。
Medicine (Baltimore). 2020 Oct 16;99(42):e22774. doi: 10.1097/MD.0000000000022774.
3
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.乳酸脱氢酶和 C 反应蛋白可预测 COVID-19 患者的呼吸衰竭。
Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9.
4
Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.COVID-19 重症和危重症患者血乳酸脱氢酶水平对住院患者病死率的预测价值。
Int J Med Sci. 2020 Aug 19;17(14):2225-2231. doi: 10.7150/ijms.47604. eCollection 2020.
5
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
6
Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.与严重新型冠状病毒病(COVID-19)患者死亡结局相关的因素:病例对照研究。
Int J Med Sci. 2020 May 18;17(9):1281-1292. doi: 10.7150/ijms.46614. eCollection 2020.
7
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.乳酸脱氢酶水平可预测 2019 冠状病毒病(COVID-19)的严重程度和死亡率:一项汇总分析。
Am J Emerg Med. 2020 Sep;38(9):1722-1726. doi: 10.1016/j.ajem.2020.05.073. Epub 2020 May 27.
8
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
9
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.乳酸脱氢酶(LDH)水平升高作为新型冠状病毒肺炎(COVID-19)严重程度和死亡率的独立危险因素。
Aging (Albany NY). 2020 Aug 14;12(15):15670-15681. doi: 10.18632/aging.103770.
10
Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.血清乳酸脱氢酶(LDH)在 2019 新型冠状病毒(COVID-19)肺炎中的潜在临床应用价值评估。
Respir Res. 2020 Jul 6;21(1):171. doi: 10.1186/s12931-020-01427-8.

引用本文的文献

1
Association between serum lactate and mortality in critically ill ischemic stroke patients based on MIMIC-IV data.基于MIMIC-IV数据的重症缺血性中风患者血清乳酸水平与死亡率之间的关联
Sci Rep. 2025 Jul 18;15(1):26155. doi: 10.1038/s41598-025-11461-5.
2
Investigation of the effect of serum gasdermin d levels on clinical course and mortality in patients with covid-19.血清Gasdermin D水平对新型冠状病毒肺炎患者临床病程及死亡率影响的研究
BMC Infect Dis. 2025 Jul 3;25(1):893. doi: 10.1186/s12879-025-11277-8.
3
Hematological Markers in Thromboembolic Events: A Comparative Study of COVID-19 and Non-COVID-19 Hospitalized Patients.

本文引用的文献

1
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
2
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
3
Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study.
血栓栓塞事件中的血液学标志物:COVID-19与非COVID-19住院患者的比较研究
J Clin Med. 2025 May 5;14(9):3192. doi: 10.3390/jcm14093192.
4
Warning indicators of COVID-19 severity: a retrospective observational study integrating modern biomarkers and traditional tongue features.新冠病毒疾病严重程度的警示指标:一项整合现代生物标志物与传统舌象特征的回顾性观察研究
Front Med (Lausanne). 2025 Apr 15;12:1500605. doi: 10.3389/fmed.2025.1500605. eCollection 2025.
5
Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome.微调许可策略以增强基于间充质干细胞的免疫调节分泌组。
Stem Cell Res Ther. 2025 Apr 17;16(1):183. doi: 10.1186/s13287-025-04315-4.
6
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach.COVID-19住院患者死亡早期生物标志物的识别:基于LASSO的Cox和Logistic方法
Viruses. 2025 Feb 28;17(3):359. doi: 10.3390/v17030359.
7
Recent advances in nutritional metabolism studies on SARS-CoV-2 infection.新型冠状病毒感染营养代谢研究的最新进展
Infect Med (Beijing). 2025 Jan 15;4(1):100162. doi: 10.1016/j.imj.2025.100162. eCollection 2025 Mar.
8
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.住院患者中发生重症 COVID-19 的预测因素:一项回顾性研究。
Front Med (Lausanne). 2025 Jan 14;11:1494302. doi: 10.3389/fmed.2024.1494302. eCollection 2024.
9
COVID-19 and HIV: Clinical Outcomes and Inflammatory Markers in a Cohort from a Reference Hospital in Rio de Janeiro, Brazil.新型冠状病毒肺炎与人类免疫缺陷病毒:巴西里约热内卢一家参考医院队列中的临床结局与炎症标志物
Viruses. 2025 Jan 13;17(1):91. doi: 10.3390/v17010091.
10
Laboratory findings predictive of critical illness in hospitalized COVID-19 patients in Tunisia.突尼斯住院COVID-19患者中预测危重症的实验室检查结果。
F1000Res. 2024 Nov 18;13:918. doi: 10.12688/f1000research.151333.2. eCollection 2024.
自身免疫性疾病所致免疫功能低下宿主社区获得性肺炎的临床特征及预后:一项回顾性观察研究
World J Emerg Med. 2020;11(3):145-151. doi: 10.5847/wjem.j.1920-8642.2020.03.003.
4
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.无症状携带者状态、急性呼吸道疾病和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的肺炎:事实与误区。
J Microbiol Immunol Infect. 2020 Jun;53(3):404-412. doi: 10.1016/j.jmii.2020.02.012. Epub 2020 Mar 4.
5
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
7
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
8
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.新兴人类致病冠状病毒 SARS-CoV、MERS-CoV 和 2019-nCoV 的病理学和发病机制的重叠和离散方面。
J Med Virol. 2020 May;92(5):491-494. doi: 10.1002/jmv.25709. Epub 2020 Feb 21.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.